UV-Induced Somatic Mutations Driving Clonal Evolution in Healthy Skin, Nevus, and Cutaneous Melanoma
- PMID: 36143375
- PMCID: PMC9503451
- DOI: 10.3390/life12091339
UV-Induced Somatic Mutations Driving Clonal Evolution in Healthy Skin, Nevus, and Cutaneous Melanoma
Abstract
Introduction: Due to its aggressiveness, cutaneous melanoma (CM) is responsible for most skin cancer-related deaths worldwide. The origin of CM is closely linked to the appearance of UV-induced somatic mutations in melanocytes present in normal skin or in CM precursor lesions (nevi or dysplastic nevi). In recent years, new NGS studies performed on CM tissue have increased the understanding of the genetic somatic changes underlying melanomagenesis and CM tumor progression.
Methods: We reviewed the literature using all important scientific databases. All articles related to genomic mutations in CM as well as normal skin and nevi were included, in particular those related to somatic mutations produced by UV radiation.
Conclusions: CM development and progression are strongly associated with exposure to UV radiation, although each melanoma subtype has different characteristic genetic alterations and evolutionary trajectories. While BRAF and NRAS mutations are common in the early stages of tumor development for most CM subtypes, changes in CDKN2A, TP53 and PTEN, together with TERT promoter mutations, are especially common in advanced stages. Additionally, large genome duplications, loss of heterozygosity, and copy number variations are hallmarks of metastatic disease. Finally, the mutations driving melanoma targeted-therapy drug resistance are also summarized. The complete sequential stages of clonal evolution leading to CM onset from normal skin or nevi are still unknown, so further studies are needed in this field to shed light on the molecular pathways involved in CM malignant transformation and in melanoma acquired drug resistance.
Keywords: UV exposure; clonal evolution; cutaneous melanoma; genomic mutations; mutational signatures; nevus.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Early contribution of germline and nevi genetic alterations to a rapidly-progressing cutaneous melanoma patient: a case report.BMC Med Genomics. 2023 Jan 5;16(1):1. doi: 10.1186/s12920-022-01426-2. BMC Med Genomics. 2023. PMID: 36604730 Free PMC article.
-
Genomic Characterization of Dysplastic Nevi Unveils Implications for Diagnosis of Melanoma.J Invest Dermatol. 2017 Apr;137(4):905-909. doi: 10.1016/j.jid.2016.11.017. Epub 2016 Nov 24. J Invest Dermatol. 2017. PMID: 27890785
-
Black and Brown Oro-facial Mucocutaneous Neoplasms.Head Neck Pathol. 2019 Mar;13(1):56-70. doi: 10.1007/s12105-019-01008-2. Epub 2019 Jan 29. Head Neck Pathol. 2019. PMID: 30693458 Free PMC article. Review.
-
The Impact of Hyaluronan on Tumor Progression in Cutaneous Melanoma.Front Oncol. 2022 Jan 21;11:811434. doi: 10.3389/fonc.2021.811434. eCollection 2021. Front Oncol. 2022. PMID: 35127523 Free PMC article. Review.
-
The Genetic Evolution of Melanoma from Precursor Lesions.N Engl J Med. 2015 Nov 12;373(20):1926-36. doi: 10.1056/NEJMoa1502583. N Engl J Med. 2015. PMID: 26559571
Cited by
-
Cutaneous Melanoma: A Review of Multifactorial Pathogenesis, Immunohistochemistry, and Emerging Biomarkers for Early Detection and Management.Int J Mol Sci. 2023 Nov 1;24(21):15881. doi: 10.3390/ijms242115881. Int J Mol Sci. 2023. PMID: 37958863 Free PMC article. Review.
-
Primary Undifferentiated/Dedifferentiated Cutaneous Melanomas-A Review on Histological, Immunohistochemical, and Molecular Features with Emphasis on Prognosis and Treatment.Int J Mol Sci. 2023 Jun 10;24(12):9985. doi: 10.3390/ijms24129985. Int J Mol Sci. 2023. PMID: 37373134 Free PMC article. Review.
-
The Benefits and Challenges of the Multimodal Treatment in Advanced/Metastatic Malignant Melanoma.Diagnostics (Basel). 2023 May 5;13(9):1635. doi: 10.3390/diagnostics13091635. Diagnostics (Basel). 2023. PMID: 37175025 Free PMC article.
-
Mechanistic insights into proteasome inhibitor MG132 induced apoptosis in melanoma A375 cells.Sci Rep. 2025 Apr 27;15(1):14731. doi: 10.1038/s41598-025-99151-0. Sci Rep. 2025. PMID: 40289224 Free PMC article.
-
Primary Cutaneous Rhabdomyosarcomatous Melanomas-A Report of Two Cases and Literature Review.Diagnostics (Basel). 2025 May 28;15(11):1357. doi: 10.3390/diagnostics15111357. Diagnostics (Basel). 2025. PMID: 40506928 Free PMC article.
References
-
- Hernando B., Dietzen M., Parra G., Gil-Barrachina M., Pitarch G., Mahiques L., Valcuende-Cavero F., McGranahan N., Martinez-Cadenas C. The Effect of Age on the Acquisition and Selection of Cancer Driver Mutations in Sun-Exposed Normal Skin. Ann. Oncol. 2021;32:412–421. doi: 10.1016/j.annonc.2020.11.023. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous